Cadrenal Therapeutics, Inc. Common Stock
CVKD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $17,671 | $9,637 | $47,934 |
| - Cash | $10,018 | $8,403 | $33 |
| + Debt | $0 | $21 | $641 |
| Enterprise Value | $7,653 | $1,256 | $48,543 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | -$1 |
| % Margin | – | – | – |
| EBITDA | -$10,649 | -$8,338 | -$6,606 |
| % Margin | – | – | – |
| Net Income | -$10,651 | -$8,357 | -$6,714 |
| % Margin | – | – | – |
| EPS Diluted | -8.73 | -9.63 | -8.66 |
| % Growth | 9.3% | -11.2% | – |
| Operating Cash Flow | -$7,358 | -$3,530 | -$1,205 |
| Capital Expenditures | -$7 | -$3 | $0 |
| Free Cash Flow | -$7,364 | -$3,534 | -$1,205 |